ITBO910113A0 - Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari - Google Patents

Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari

Info

Publication number
ITBO910113A0
ITBO910113A0 IT91BO113A ITBO910113A ITBO910113A0 IT BO910113 A0 ITBO910113 A0 IT BO910113A0 IT 91BO113 A IT91BO113 A IT 91BO113A IT BO910113 A ITBO910113 A IT BO910113A IT BO910113 A0 ITBO910113 A0 IT BO910113A0
Authority
IT
Italy
Prior art keywords
castro
pharmaceutical formulations
oral use
bile acids
use containing
Prior art date
Application number
IT91BO113A
Other languages
English (en)
Inventor
Egidio Marchi
Gianfranco Tamagnone
Leone Gabriele Rotini
Original Assignee
Alfa Wassermann
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alfa Wassermann filed Critical Alfa Wassermann
Publication of ITBO910113A0 publication Critical patent/ITBO910113A0/it
Priority to ITBO910113A priority Critical patent/IT1245890B/it
Priority to US07/861,466 priority patent/US5380533A/en
Priority to EP92105716A priority patent/EP0509335B1/en
Priority to ES92105716T priority patent/ES2090395T3/es
Priority to DE69212879T priority patent/DE69212879T2/de
Priority to JP4091130A priority patent/JP2509045B2/ja
Priority to CA002065773A priority patent/CA2065773C/en
Priority to KR1019920006052A priority patent/KR970005176B1/ko
Publication of ITBO910113A1 publication Critical patent/ITBO910113A1/it
Application granted granted Critical
Publication of IT1245890B publication Critical patent/IT1245890B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ITBO910113A 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. IT1245890B (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.
US07/861,466 US5380533A (en) 1991-04-12 1992-04-01 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
DE69212879T DE69212879T2 (de) 1991-04-12 1992-04-02 Magensaftstabile pharmazeutische Formulierungen zur Oral Verbreichung von Gallensäuren
ES92105716T ES2090395T3 (es) 1991-04-12 1992-04-02 Formulados farmaceuticos gastroresistentes para administracion por via oral que contienen acidos biliares.
EP92105716A EP0509335B1 (en) 1991-04-12 1992-04-02 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
JP4091130A JP2509045B2 (ja) 1991-04-12 1992-04-10 胆汁酸を含有する経口投与用の胃液耐性のある製剤
CA002065773A CA2065773C (en) 1991-04-12 1992-04-10 Gastroresistant pharmaceutical formulations for oral administration containing bile acids
KR1019920006052A KR970005176B1 (ko) 1991-04-12 1992-04-11 담즙산을 함유하는 경구용 위내성 의약 포뮬레이션

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Publications (3)

Publication Number Publication Date
ITBO910113A0 true ITBO910113A0 (it) 1991-04-12
ITBO910113A1 ITBO910113A1 (it) 1992-10-12
IT1245890B IT1245890B (it) 1994-10-25

Family

ID=11337390

Family Applications (1)

Application Number Title Priority Date Filing Date
ITBO910113A IT1245890B (it) 1991-04-12 1991-04-12 Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari.

Country Status (8)

Country Link
US (1) US5380533A (it)
EP (1) EP0509335B1 (it)
JP (1) JP2509045B2 (it)
KR (1) KR970005176B1 (it)
CA (1) CA2065773C (it)
DE (1) DE69212879T2 (it)
ES (1) ES2090395T3 (it)
IT (1) IT1245890B (it)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5262172A (en) * 1992-06-19 1993-11-16 Digestive Care Inc. Compositions of gastric acid-resistant microspheres containing buffered bile acids
GB9417524D0 (en) * 1994-08-31 1994-10-19 Cortecs Ltd Pharmaceutical compositions
KR100578669B1 (ko) * 1997-05-29 2006-12-07 동아제약주식회사 우르소데옥시콜린산을함유하는투명연질캅셀
DE29717252U1 (de) * 1997-09-26 1998-02-19 Falk Pharma Gmbh Arzneimittelkit aus einem Budesonid-haltigen und einem Ursodesoxycholsäure-haltigen Arzneimittel zur Behandlung von cholestatischen Lebererkrankungen
US7772220B2 (en) * 2004-10-15 2010-08-10 Seo Hong Yoo Methods and compositions for reducing toxicity of a pharmaceutical compound
RU2224523C2 (ru) 1998-07-24 2004-02-27 Сео Хонг Ю Водный раствор, содержащий желчную кислоту, и способ его получения
US7303768B2 (en) 1998-07-24 2007-12-04 Seo Hong Yoo Preparation of aqueous clear solution dosage forms with bile acids
US20050158408A1 (en) * 1998-07-24 2005-07-21 Yoo Seo H. Dried forms of aqueous solubilized bile acid dosage formulation: preparation and uses thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
DE19906290A1 (de) * 1999-02-15 2000-08-17 Falk Pharma Gmbh Arzneimittel zur Behandlung bzw. Prävention von Darmkrebs
BR0108080A (pt) * 2000-02-04 2006-02-07 Seo Hong Yoo Preparação de formas de dosagem de solução clara aquosa com ácidos biliares
PL357674A1 (en) * 2000-04-19 2004-07-26 Thomas Julius Borody Compositions and therapies for hyperlipidaemia-associated disorders
US7166234B1 (en) * 2000-10-26 2007-01-23 Integrated Biomedical Technology, Inc. Dialdehyde assay
KR100368936B1 (ko) * 2000-10-04 2003-01-24 주식회사 대웅 우루소데옥시콜린산을 함유한 환경호르몬 독성의 예방 및치료제
CA2403670C (en) * 2001-01-31 2010-02-09 Rohm Gmbh & Co. Kg Multiparticulate drug form comprising at least two differently coated pellet forms
ITMI20012572A1 (it) * 2001-12-06 2003-06-06 Istituto Biochimico Italiano Microgranuli di acido ursodesossicolico
US7145125B2 (en) * 2003-06-23 2006-12-05 Advanced Optical Technologies, Llc Integrating chamber cone light using LED sources
TW200533391A (en) * 2004-03-25 2005-10-16 Sun Pharmaceutical Ind Ltd Gastric retention drug delivery system
ATE458489T1 (de) * 2004-08-30 2010-03-15 Seo Hong Yoo Nervenschutzwirkung von aufgelöster udca bei einem fokalen ischämischen modell
ATE506955T1 (de) * 2004-10-15 2011-05-15 Seo Hong Yoo Zusammensetzungen zur verringerung der toxizität von cisplatin, carboplatin und oxaliplatin
WO2006050165A2 (en) * 2004-11-01 2006-05-11 Seo Hong Yoo Methods and compositions for reducing neurodegeneration in amyotrophic lateral sclerosis
CN102316889B (zh) 2008-11-26 2014-11-26 萨蒂奥根制药公司 组合物及使用方法
CA2744817C (en) 2008-11-26 2020-07-07 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors for treatment of obesity and diabetes
BRPI1006145B8 (pt) * 2009-01-12 2021-05-25 Biokier Inc composição e método para tratamento de diabetes
US9314444B2 (en) 2009-01-12 2016-04-19 Biokier, Inc. Composition and method for treatment of NASH
US9006288B2 (en) 2009-01-12 2015-04-14 Biokier, Inc. Composition and method for treatment of diabetes
WO2011038014A2 (en) 2009-09-23 2011-03-31 Biokier, Inc. Composition and method for treatment of diabetes
US20110152204A1 (en) * 2009-12-18 2011-06-23 Satiogen Pharmaceuticals, Inc. Treatment of Obesity or Diabetes with Bile Acid Sequestrants
EP3593802A3 (en) 2010-05-26 2020-03-25 Satiogen Pharmaceuticals, Inc. Bile acid recycling inhibitors and satiogens for treatment of diabetes, obesity, and inflammatory gastrointestinal conditions
PL2771003T3 (pl) 2011-10-28 2017-10-31 Lumena Pharmaceuticals Llc Inhibitory ponownego wykorzystania kwasów żółciowych do leczenia pediatrycznych cholestatycznych chorób wątroby
WO2015142178A1 (en) 2014-03-20 2015-09-24 Disphar International B.V. Bile acid composition with enhanced solubility

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2340060A1 (de) * 1973-08-08 1975-02-20 Scherer Gmbh R P Magensaftresistente gelatinekapseln und verfahren zu deren herstellung
FR2358144A1 (fr) * 1976-07-13 1978-02-10 Lipha Nouvelle composition medicamenteuse pour le traitement de la lithiase biliaire
IT1101649B (it) * 1978-12-15 1985-10-07 Lehner Ag Composizione farmaceutica ad azione prolungata contenente acidi biliari
IL68769A (en) * 1983-05-23 1986-02-28 Hadassah Med Org Pharmaceutical compositions containing insulin for oral administration
AT389308B (de) * 1984-12-12 1989-11-27 Medica Pharma Co Ltd Verfahren zur herstellung von neuem haeminarginat bzw. haeminlysinat
GB2189699A (en) * 1986-04-30 1987-11-04 Haessle Ab Coated acid-labile medicaments
IT1197038B (it) * 1986-08-01 1988-11-25 Zambon Spa Composizione farmaceutica ad attivita' analgesica
IT1212141B (it) * 1987-06-03 1989-11-08 So Ri Far S R L Composizioni farmaceutiche per la prevenzione e terapia della calcolosi delle vie biliari e della dispepsia biliare.
YU183988A (en) * 1988-09-30 1990-08-31 Lek Tovarna Farmacevtskih Process for preparing dispersion pills of dihydroergotoxine

Also Published As

Publication number Publication date
EP0509335B1 (en) 1996-08-21
DE69212879D1 (de) 1996-09-26
CA2065773C (en) 1999-01-26
JPH0597676A (ja) 1993-04-20
KR970005176B1 (ko) 1997-04-14
DE69212879T2 (de) 1997-01-23
IT1245890B (it) 1994-10-25
CA2065773A1 (en) 1992-10-13
ES2090395T3 (es) 1996-10-16
JP2509045B2 (ja) 1996-06-19
ITBO910113A1 (it) 1992-10-12
EP0509335A1 (en) 1992-10-21
KR920019359A (ko) 1992-11-19
US5380533A (en) 1995-01-10

Similar Documents

Publication Publication Date Title
ITBO910113A0 (it) Formulazioni farmaceutiche per uso orale castroresistenti contenenti acidi biliari
ITBO910112A0 (it) Formulazioni farmaceutiche per uso orale gastroresistenti contenenti sali di acidi biliari
ITBO910024A0 (it) Formulazioni farmaceutiche contenenti glicosaminoglicani assorbibili per via orale
FI934914A (fi) Farmaceutiska formuleringar
DK481989D0 (da) Farmaceutiske formuleringer
DK0515312T3 (da) Farmaceutisk præparat
EE03108B1 (et) Farmatseutiline kompositsioon
FI981777A0 (fi) Farmaseuttinen ainekoostumus
DE69621885D1 (de) Neue galenische orale pharmazeutische formulierung
ITBO910114A0 (it) Formulazioni farmaceutiche a rilascio controllato per uso orale ga- stroresistenti contenenti acidi biliari e loro sali
IT1231012B (it) Composizione farmaceutica per uso orale contenente nac.
EE03744B1 (et) Valproehapet sisaldavad farmatseutilised mikrokerakesed oraalseks manustamiseks
MX9200622A (es) Composicion farmaceutica
ITTO920303A0 (it) "composizione farmaceutica antiinfiammatoria"
DK0511991T3 (da) Farmaceutisk formulering
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
FI952377A (fi) Farmaseuttisia ibuprofeenikoostumuksia
IT1243341B (it) Composizione farmaceutica per uso orale a rilascio modificato di antiinfiammatori non steroidei
ITPD920141A0 (it) Formulazione farmaceutiche per la somministraziane orale di calcitoni-na
IT8922279A0 (it) Formulazioni farmaceutiche per uso topico
ITMI912766A1 (it) Composizione farmaceutica contenente n-acetil-cisteina
SE9103213D0 (sv) Farmaceutisk komposition
SE9101348D0 (sv) Pharmaceutical composition

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970423